BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22552880)

  • 1. Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Ye H; Lv M; Zhao X; Zhao X; Huang X
    Int J Hematol; 2012 Jun; 95(6):680-8. PubMed ID: 22552880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.
    Lv M; Ye HG; Zhao XS; Zhao XY; Chang YJ; Liu DH; Xu LP; Huang XJ
    PLoS One; 2013; 8(3):e58735. PubMed ID: 23505556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
    Rezvani AR; Storer BE; Storb RF; Mielcarek M; Maloney DG; Sandmaier BM; Martin PJ; McDonald GB
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1594-601. PubMed ID: 21806949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Shin J; Dan K; Han D; Kim JW; Kim KK; Koh Y; Shin DY; Hong J; Yoon SS; Park S; Song SH; Kim I
    Blood Cells Mol Dis; 2019 Feb; 74():5-12. PubMed ID: 30344086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Liu S; Han J; Gong H; Li Y; Bao X; Qi J; Liu H; Chen J; Wu X; Xu Y; Ma S; Wu D
    Sci Rep; 2018 Jul; 8(1):10328. PubMed ID: 29985424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
    Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.
    Wu X; Xie Y; Wang C; Han Y; Bao X; Ma S; Yilmaz A; Yang B; Ji Y; Xu J; Liu H; Chen S; Zhang J; Yu J; Wu D
    JCI Insight; 2018 May; 3(9):. PubMed ID: 29720575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
    Pedraza A; Salas MQ; Rodríguez-Lobato LG; Escribano-Serrat S; Suárez-Lledo M; Martínez-Cebrian N; Solano MT; Arcarons J; Rosiñol L; Gutiérrez-García G; Fernández-Avilés F; Moreno-Castaño AB; Molina P; Pino M; Carreras E; Díaz-Ricart M; Rovira M; Palomo M; Martínez C
    Transplant Cell Ther; 2024 Feb; 30(2):187.e1-187.e12. PubMed ID: 38000709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 14. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
    Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
    Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease.
    Sakata N; Yasui M; Okamura T; Inoue M; Yumura-Yagi K; Kawa K
    Bone Marrow Transplant; 2001 Jun; 27(11):1153-61. PubMed ID: 11551026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between serum levels of IL-18 and acute graft versus host disease in patients after allogeneic hematopoietic stem cell transplantation].
    Liu J; Zhang XG; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):553-7. PubMed ID: 17605864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
    Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
    J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
    Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
    Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Zhang X; Zhou Y; Xu L; Han W; Chen H; Chen Y; Fu H; Zhou S; Zhao J; Wang Q; Feng F; Zhu X; Liu K; Huang X
    Ann Hematol; 2015 May; 94(5):837-45. PubMed ID: 25512184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
    Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.